Comparison of nasal congestion difference post lefort surgery

Comparison of nasal congestion difference post lefort surgery using mometasone furoate vs phenylephrine nasal spray

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180312039060N5

Enrollment

Registered

2024-12-28

Start date

2025-01-20

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasal congestion.

Interventions

Intervention 1: Patients will be randomly assigned to the intervention group (Mometasone Nasonex = Mometasone Furoate 0.05%, Organon). After surgery, each drug will be sprayed three times a day for 3

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Maxillary orthognathic surgery Absence of sinus and allergic disease Absence of craniofacial syndromes and cleft lip and palate Absence of sinus medication

Exclusion criteria

Exclusion criteria: Patient's unwillingness to participate in the study

Design outcomes

Primary

Measure	Time frame
Average score of the standard SNOT 20 (sino-nasal outcome test) questionnaire. Timepoint: On the third and tenth day after surgery. Method of measurement: The standard SNOT 20 (sino-nasal outcome test) questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Ebrahimpour

Mashhad University of Medical Sciences

alireza.ebrahimpour.1996@gmail.com+98 11 4326 0653

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026